Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) serves as a notification to the Securities and Exchange Commission regarding the submission of its Annual Report 2010 on Form 20-F. The filing was made on March 4, 2011, and covers the fiscal year ended December 31, 2010. The report includes audited financial statements for the specified period.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts solely as a reference to the Form 20-F, which contains the detailed audited financial data.
Material Changes
The filing text does not provide information regarding material changes versus the prior comparable period. Investors are directed to the Annual Report 2010 on Form 20-F for comparative financial analysis.
Guidance, Outlook, and Risks
GSK includes a cautionary statement regarding forward-looking statements, noting that projections are subject to risks and uncertainties that may cause actual results to differ materially. Specific factors affecting operations are detailed under the 'Risk factors' section within the 'Business review' of the Annual Report 2010 on Form 20-F. No specific guidance or outlook figures are included in this summary filing.
Important Facts for Investors to Verify
- The audited financial statements for the year ended December 31, 2010, are contained in the Form 20-F filed on March 4, 2011.
- The Annual Report 2010 is available online at www.gsk.com/corporatereporting and www.sec.gov.
- Hard copies of the Annual Report and the Notice of Annual General Meeting were expected to be available on or about March 21, 2011.
- Shareholders may request free hard copies of the audited financial statements via Equiniti (UK), BNY Mellon Shareowner Services (US), or the GSK Response Center (US).
- Forward-looking statements in related reports are subject to risks described in the Form 20-F.